600 patients66,869 observations120 daysLIVE

Patient P-01458

Synthetic patientNBL-101 · Day 117 · 55–64 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Stable
Nutritional resilience
Declining
Discontinuation risk
75%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 46 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 59 GI-04 recommendedGI Support Protocol GI-04
  4. Day 60 Patient acceptedStarted GI-04 in the companion
  5. Day 68 GI symptom burden −38% vs expectedGI Support Protocol GI-04
  6. Day 74 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 46.

Primary contributors, last 14 days
  • GI instability+12
  • Toxicity-9
  • Nutritional resilience-4
  • Treatment adherence-3

What helped?

  • GI Support Protocol GI-04Day 59
    Result: symptom burden −38%
LIFE OS recommendation
Dietary Support Protocol NP-02
63%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
49.5/100
stable · +1.7 vs previous 14 d
Toxicity
Blood
37.1/100
worsening · +5.7 vs previous 14 d
Sleep quality
Wearable
35.8/100
stable · +0.5 vs previous 14 d
Energy level
Daily log
3.5/10
worsening · -0.4 vs previous 14 d
Stress level
Daily log
5.7/10
worsening · +0.4 vs previous 14 d
Steps
Wearable
3,188
stable · +43 vs previous 14 d
Adherence
Companion
52.1 %
stable · +1.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 35 from the failing basin, 52 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 77%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 77%
  • CR-01 Clinician Review
    100% improved among 8 similar · onset 5 d · confidence 77%
Would not help
  • Keep histamine low
    GI +4.2 next day on high-intake days · n 17
  • Keep simple carbs low
    GI +3.6 next day on high-intake days · n 14
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Histamine load
    +4.2detractor · 95%
  • Simple carbohydrates
    +3.6detractor · 86%
  • Insoluble fibre
    +1.6no signal · 27%
  • Spicy / capsaicin
    +1.3no signal · 27%
  • Dietary fat load
    +1no signal · 22%
  • Alcohol
    +0.6no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Drug metabolism and exposure 75
    • DNACYP2D6 poor metabolizer → higher exposure
    • DNADPYD *2A → slower clearance
  • Mucosal barrier integrity 50
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Daily logGI symptom score 50 and rising
  • Butyrate / short-chain fatty acid production 45
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 74 bpm
    • Wearable3,188 steps/day
  • Inflammatory signalling 25
    • BloodInflammatory load index 46
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2.8 · butyrate capacity 46/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
45 ms
Sleep
6.9 h
Steps
2,419
Resting HR
76 bpm
Daily log: GI score 50, nutritional resilience 48, adherence 52.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0160425%S0171
P-0138625%S1370
P-0135225%S2070
P-0175026%S1669
P-0169930%S04GI-04improved69
P-0150825%S1868
P-0150927%S1768
P-0181726%S1467
P-0187727%S01CR-01improved67
P-0162926%S1966
P-0171435%S14GI-04improved66
P-0185839%S14NP-02improved65